Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 21 | 2013 | 418 | 1.720 |
Why?
|
Biopsy, Fine-Needle | 2 | 2014 | 115 | 0.750 |
Why?
|
Carcinoma | 5 | 2012 | 287 | 0.620 |
Why?
|
Adenocarcinoma | 6 | 2022 | 1023 | 0.560 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2015 | 1 | 0.510 |
Why?
|
Chondrosarcoma | 1 | 2015 | 11 | 0.500 |
Why?
|
Foot Diseases | 1 | 2015 | 24 | 0.500 |
Why?
|
Fibroma | 1 | 2015 | 28 | 0.490 |
Why?
|
Ovary | 7 | 2010 | 380 | 0.460 |
Why?
|
Carcinoma, Endometrioid | 4 | 2011 | 15 | 0.460 |
Why?
|
Breast Neoplasms | 9 | 2016 | 2509 | 0.450 |
Why?
|
Esophageal Neoplasms | 3 | 2024 | 372 | 0.440 |
Why?
|
Bronchoscopy | 1 | 2014 | 151 | 0.440 |
Why?
|
Ultrasonography, Interventional | 1 | 2014 | 194 | 0.410 |
Why?
|
Endoscopy | 1 | 2014 | 279 | 0.400 |
Why?
|
Lung Neoplasms | 3 | 2021 | 1660 | 0.390 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 190 | 0.390 |
Why?
|
Immunohistochemistry | 12 | 2018 | 1694 | 0.370 |
Why?
|
Breast Neoplasms, Male | 1 | 2009 | 15 | 0.320 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2012 | 618 | 0.310 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2010 | 178 | 0.310 |
Why?
|
beta Catenin | 1 | 2009 | 203 | 0.300 |
Why?
|
MutS Homolog 2 Protein | 2 | 2006 | 39 | 0.280 |
Why?
|
Biomarkers, Tumor | 9 | 2013 | 1492 | 0.280 |
Why?
|
Barrett Esophagus | 2 | 2022 | 340 | 0.270 |
Why?
|
Microsatellite Instability | 1 | 2006 | 36 | 0.270 |
Why?
|
Epithelial Cells | 6 | 2016 | 909 | 0.260 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 673 | 0.260 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2006 | 11 | 0.260 |
Why?
|
Tissue Array Analysis | 7 | 2011 | 137 | 0.240 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 556 | 0.240 |
Why?
|
Adenocarcinoma, Mucinous | 4 | 2013 | 37 | 0.230 |
Why?
|
Tissue Embedding | 1 | 2004 | 4 | 0.230 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2013 | 52 | 0.230 |
Why?
|
Influenza, Human | 1 | 2010 | 656 | 0.220 |
Why?
|
Esophagoscopy | 1 | 2024 | 155 | 0.220 |
Why?
|
Microscopy | 1 | 2024 | 119 | 0.210 |
Why?
|
Lung | 1 | 2010 | 1496 | 0.200 |
Why?
|
Telomerase | 4 | 2012 | 160 | 0.200 |
Why?
|
Neoplasm Staging | 7 | 2018 | 1278 | 0.200 |
Why?
|
Adenocarcinoma, Clear Cell | 4 | 2013 | 24 | 0.200 |
Why?
|
Carrier Proteins | 2 | 2006 | 1024 | 0.190 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2023 | 341 | 0.190 |
Why?
|
Veterans | 3 | 2022 | 1749 | 0.190 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 2043 | 0.180 |
Why?
|
Humans | 45 | 2024 | 124705 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2008 | 1892 | 0.180 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 360 | 0.180 |
Why?
|
Receptors, Estrogen | 5 | 2008 | 795 | 0.180 |
Why?
|
Middle Aged | 18 | 2024 | 26884 | 0.180 |
Why?
|
Nuclear Proteins | 2 | 2006 | 1266 | 0.180 |
Why?
|
Cell Degranulation | 1 | 2020 | 29 | 0.180 |
Why?
|
Female | 35 | 2024 | 66577 | 0.170 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 27 | 0.170 |
Why?
|
Duodenum | 1 | 2020 | 99 | 0.170 |
Why?
|
Precancerous Conditions | 2 | 2022 | 282 | 0.170 |
Why?
|
Eosinophils | 1 | 2020 | 118 | 0.170 |
Why?
|
Dyspepsia | 1 | 2020 | 100 | 0.160 |
Why?
|
Prognosis | 7 | 2015 | 4620 | 0.160 |
Why?
|
Aged | 15 | 2024 | 19830 | 0.160 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2013 | 197 | 0.160 |
Why?
|
Eosinophilia | 1 | 2020 | 100 | 0.160 |
Why?
|
Aged, 80 and over | 9 | 2018 | 6584 | 0.160 |
Why?
|
Adult | 17 | 2020 | 29554 | 0.160 |
Why?
|
Sulfur-Reducing Bacteria | 1 | 2018 | 2 | 0.160 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2012 | 39 | 0.150 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 397 | 0.150 |
Why?
|
Colitis, Microscopic | 1 | 2018 | 15 | 0.150 |
Why?
|
Thrombocytopenia | 1 | 2020 | 224 | 0.150 |
Why?
|
Interleukin-17 | 1 | 2018 | 120 | 0.140 |
Why?
|
Biopsy | 3 | 2024 | 1234 | 0.130 |
Why?
|
CELF1 Protein | 1 | 2016 | 48 | 0.130 |
Why?
|
Fibrin | 1 | 2016 | 64 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 2 | 2007 | 204 | 0.120 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 216 | 0.120 |
Why?
|
Oncolytic Viruses | 1 | 2016 | 73 | 0.120 |
Why?
|
Cell Movement | 3 | 2016 | 846 | 0.120 |
Why?
|
Coronavirus Infections | 1 | 2020 | 356 | 0.120 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 370 | 0.120 |
Why?
|
Image-Guided Biopsy | 1 | 2014 | 36 | 0.120 |
Why?
|
Nephrotic Syndrome | 2 | 2005 | 47 | 0.110 |
Why?
|
Disease-Free Survival | 3 | 2014 | 898 | 0.110 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 227 | 0.110 |
Why?
|
RNA, Small Interfering | 5 | 2008 | 664 | 0.110 |
Why?
|
Male | 12 | 2024 | 61317 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 1291 | 0.110 |
Why?
|
Mice, Nude | 4 | 2012 | 709 | 0.110 |
Why?
|
Neoplasm, Residual | 1 | 2014 | 123 | 0.110 |
Why?
|
Reproducibility of Results | 2 | 2014 | 2885 | 0.110 |
Why?
|
Oncogenes | 1 | 2014 | 167 | 0.110 |
Why?
|
CA-125 Antigen | 1 | 2013 | 15 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 1052 | 0.110 |
Why?
|
Homeodomain Proteins | 2 | 2007 | 549 | 0.100 |
Why?
|
Adenoviridae | 1 | 2016 | 606 | 0.100 |
Why?
|
Hemorrhage | 2 | 2020 | 468 | 0.100 |
Why?
|
Models, Biological | 2 | 2016 | 1460 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 505 | 0.100 |
Why?
|
Endometrial Neoplasms | 1 | 2013 | 98 | 0.100 |
Why?
|
Cell Line, Tumor | 7 | 2016 | 3344 | 0.100 |
Why?
|
Feasibility Studies | 1 | 2014 | 759 | 0.100 |
Why?
|
Fallopian Tubes | 1 | 2012 | 73 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 429 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 488 | 0.090 |
Why?
|
Carcinogenesis | 1 | 2014 | 333 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2008 | 83 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2011 | 45 | 0.090 |
Why?
|
Gastrointestinal Microbiome | 1 | 2018 | 702 | 0.090 |
Why?
|
Mice | 10 | 2023 | 17645 | 0.090 |
Why?
|
Cell Line, Transformed | 2 | 2012 | 169 | 0.090 |
Why?
|
DNA Damage | 1 | 2014 | 513 | 0.090 |
Why?
|
Tracheitis | 1 | 2010 | 14 | 0.090 |
Why?
|
Autopsy | 1 | 2010 | 111 | 0.090 |
Why?
|
Disease Progression | 3 | 2022 | 2057 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 1873 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 2161 | 0.080 |
Why?
|
Necrosis | 1 | 2010 | 207 | 0.080 |
Why?
|
Peritoneum | 1 | 2010 | 37 | 0.080 |
Why?
|
Mitotic Index | 1 | 2009 | 19 | 0.080 |
Why?
|
Autophagy | 2 | 2014 | 393 | 0.080 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 135 | 0.080 |
Why?
|
Transfection | 3 | 2007 | 1069 | 0.080 |
Why?
|
Antigens, CD | 1 | 2011 | 431 | 0.080 |
Why?
|
MutL Protein Homolog 1 | 2 | 2006 | 53 | 0.080 |
Why?
|
Glycoproteins | 1 | 2011 | 370 | 0.080 |
Why?
|
Bronchiolitis | 1 | 2010 | 120 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2010 | 70 | 0.080 |
Why?
|
Kidney Transplantation | 2 | 2005 | 642 | 0.080 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2009 | 40 | 0.080 |
Why?
|
Annexin A1 | 1 | 2008 | 5 | 0.080 |
Why?
|
Animals | 12 | 2023 | 34235 | 0.080 |
Why?
|
Isoenzymes | 1 | 2009 | 228 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2022 | 16263 | 0.070 |
Why?
|
Peptides | 1 | 2011 | 810 | 0.070 |
Why?
|
RNA, Viral | 1 | 2010 | 538 | 0.070 |
Why?
|
Proteinuria | 2 | 2005 | 101 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2007 | 584 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 2524 | 0.070 |
Why?
|
Breast | 1 | 2009 | 214 | 0.070 |
Why?
|
Prospective Studies | 2 | 2016 | 6132 | 0.070 |
Why?
|
Cell Membrane | 1 | 2009 | 462 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 1143 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2007 | 55 | 0.070 |
Why?
|
Gene Products, env | 1 | 2007 | 15 | 0.070 |
Why?
|
Neoplasm Invasiveness | 3 | 2016 | 620 | 0.070 |
Why?
|
Endogenous Retroviruses | 1 | 2007 | 17 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2009 | 678 | 0.070 |
Why?
|
Gene Expression | 2 | 2008 | 1561 | 0.070 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2006 | 7 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2006 | 15 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2006 | 8 | 0.070 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 9 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2008 | 418 | 0.070 |
Why?
|
Retinoblastoma Protein | 1 | 2006 | 78 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2006 | 70 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2008 | 878 | 0.060 |
Why?
|
Antigens, Viral, Tumor | 1 | 2006 | 47 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 101 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 558 | 0.060 |
Why?
|
Prostatic Hyperplasia | 1 | 2006 | 117 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 553 | 0.060 |
Why?
|
Survival Rate | 4 | 2013 | 2055 | 0.060 |
Why?
|
Acetyltransferases | 1 | 2005 | 90 | 0.060 |
Why?
|
CpG Islands | 1 | 2007 | 324 | 0.060 |
Why?
|
Comorbidity | 1 | 2010 | 1530 | 0.060 |
Why?
|
Signal Transduction | 3 | 2014 | 4534 | 0.060 |
Why?
|
rho GTP-Binding Proteins | 1 | 2006 | 68 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2005 | 136 | 0.060 |
Why?
|
Biomarkers | 2 | 2018 | 3083 | 0.060 |
Why?
|
Mullerian Ducts | 1 | 2005 | 33 | 0.060 |
Why?
|
Iodides | 1 | 2024 | 15 | 0.060 |
Why?
|
Simian virus 40 | 1 | 2006 | 199 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 410 | 0.060 |
Why?
|
Myosin Type IV | 1 | 2004 | 1 | 0.060 |
Why?
|
Coloring Agents | 1 | 2024 | 77 | 0.060 |
Why?
|
Body Mass Index | 1 | 2010 | 1562 | 0.060 |
Why?
|
Cell Proliferation | 3 | 2016 | 2303 | 0.060 |
Why?
|
Ki-67 Antigen | 1 | 2004 | 113 | 0.060 |
Why?
|
Tissue Fixation | 1 | 2004 | 38 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 3560 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2014 | 1290 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 63 | 0.060 |
Why?
|
China | 1 | 2024 | 245 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2011 | 258 | 0.050 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2008 | 557 | 0.050 |
Why?
|
Printing, Three-Dimensional | 1 | 2024 | 69 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2004 | 221 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2023 | 3742 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2006 | 1578 | 0.050 |
Why?
|
Robotics | 1 | 2024 | 108 | 0.050 |
Why?
|
Equipment Design | 1 | 2024 | 598 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2024 | 173 | 0.050 |
Why?
|
Texas | 1 | 2010 | 3561 | 0.050 |
Why?
|
Trans-Activators | 1 | 2005 | 799 | 0.050 |
Why?
|
Hyperplasia | 1 | 2022 | 208 | 0.050 |
Why?
|
Neoplasms | 1 | 2016 | 2780 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2004 | 546 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2023 | 4396 | 0.040 |
Why?
|
DNA Methylation | 1 | 2007 | 1008 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 686 | 0.040 |
Why?
|
Transcription Factors | 2 | 2007 | 2594 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 722 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2006 | 3055 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 670 | 0.040 |
Why?
|
Aurora Kinases | 2 | 2011 | 32 | 0.040 |
Why?
|
Drosophila | 1 | 2004 | 775 | 0.040 |
Why?
|
Software | 1 | 2024 | 683 | 0.040 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 144 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 1238 | 0.040 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2021 | 241 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2007 | 1529 | 0.040 |
Why?
|
Aurora Kinase A | 2 | 2011 | 39 | 0.040 |
Why?
|
Actinomyces | 1 | 2018 | 4 | 0.040 |
Why?
|
Actinobacteria | 1 | 2018 | 13 | 0.040 |
Why?
|
Bacillus | 1 | 2018 | 35 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2024 | 605 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 278 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 313 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2018 | 57 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 116 | 0.040 |
Why?
|
United States | 2 | 2024 | 10866 | 0.040 |
Why?
|
Th17 Cells | 1 | 2018 | 91 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2018 | 329 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 1546 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 369 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2018 | 3293 | 0.030 |
Why?
|
Betacoronavirus | 1 | 2020 | 286 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2008 | 419 | 0.030 |
Why?
|
Colonoscopy | 1 | 2018 | 236 | 0.030 |
Why?
|
Protein Array Analysis | 1 | 2016 | 101 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 306 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 259 | 0.030 |
Why?
|
Blotting, Western | 2 | 2010 | 1103 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2016 | 2821 | 0.030 |
Why?
|
Risk Factors | 2 | 2022 | 10249 | 0.030 |
Why?
|
Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2016 | 28 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2016 | 211 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 258 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 2048 | 0.030 |
Why?
|
Receptor, ErbB-2 | 2 | 2010 | 514 | 0.030 |
Why?
|
Cell Cycle | 1 | 2018 | 616 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2016 | 96 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2007 | 1062 | 0.030 |
Why?
|
Infant | 1 | 2010 | 12384 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 822 | 0.030 |
Why?
|
Mice, SCID | 1 | 2016 | 564 | 0.030 |
Why?
|
Prevalence | 1 | 2021 | 2446 | 0.030 |
Why?
|
Cyclin E | 1 | 2014 | 30 | 0.030 |
Why?
|
Cell Survival | 1 | 2016 | 812 | 0.030 |
Why?
|
Stromal Cells | 1 | 2016 | 302 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2023 | 4406 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 351 | 0.030 |
Why?
|
Macrophages | 1 | 2018 | 621 | 0.030 |
Why?
|
Young Adult | 3 | 2013 | 9023 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 663 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 79 | 0.030 |
Why?
|
Organoids | 1 | 2016 | 282 | 0.030 |
Why?
|
Pandemics | 1 | 2020 | 1104 | 0.030 |
Why?
|
PAX8 Transcription Factor | 1 | 2012 | 14 | 0.020 |
Why?
|
Keratins | 1 | 2012 | 54 | 0.020 |
Why?
|
Graft Survival | 2 | 2005 | 536 | 0.020 |
Why?
|
Neoplasm Grading | 1 | 2013 | 274 | 0.020 |
Why?
|
Paired Box Transcription Factors | 1 | 2012 | 74 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 341 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2012 | 88 | 0.020 |
Why?
|
Base Sequence | 2 | 2007 | 3101 | 0.020 |
Why?
|
Risk | 1 | 2014 | 752 | 0.020 |
Why?
|
AC133 Antigen | 1 | 2011 | 35 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 3891 | 0.020 |
Why?
|
Cohort Studies | 1 | 2020 | 4799 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 158 | 0.020 |
Why?
|
Inflammation | 1 | 2018 | 1440 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 1357 | 0.020 |
Why?
|
Genomics | 1 | 2018 | 1501 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 75 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2018 | 3415 | 0.020 |
Why?
|
Apoptosis | 2 | 2007 | 1802 | 0.020 |
Why?
|
Retinal Dehydrogenase | 1 | 2009 | 10 | 0.020 |
Why?
|
Connexin 26 | 1 | 2008 | 14 | 0.020 |
Why?
|
Connexins | 1 | 2008 | 60 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 145 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 152 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2008 | 229 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2008 | 179 | 0.020 |
Why?
|
Genes, BRCA2 | 1 | 2007 | 41 | 0.020 |
Why?
|
Genes, BRCA1 | 1 | 2007 | 50 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 126 | 0.020 |
Why?
|
Genes, Homeobox | 1 | 2007 | 70 | 0.020 |
Why?
|
Ovariectomy | 1 | 2007 | 183 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2007 | 24 | 0.020 |
Why?
|
Tumor Necrosis Factor Decoy Receptors | 1 | 2006 | 1 | 0.020 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2006 | 43 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2006 | 106 | 0.020 |
Why?
|
Phenotype | 1 | 2016 | 4258 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2007 | 458 | 0.020 |
Why?
|
Karyotyping | 1 | 2006 | 323 | 0.020 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 24 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 303 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2006 | 158 | 0.020 |
Why?
|
Calpain | 1 | 2006 | 41 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1016 | 0.020 |
Why?
|
Genomic Imprinting | 1 | 2006 | 124 | 0.010 |
Why?
|
Histone Acetyltransferases | 1 | 2005 | 314 | 0.010 |
Why?
|
Phosphorylation | 1 | 2008 | 1631 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 659 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2009 | 725 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 802 | 0.010 |
Why?
|
RNA, Antisense | 1 | 2004 | 34 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 462 | 0.010 |
Why?
|
Cell Size | 1 | 2004 | 82 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 656 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2013 | 5154 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2004 | 375 | 0.010 |
Why?
|
Creatinine | 1 | 2005 | 391 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 701 | 0.010 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2005 | 348 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 1330 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 213 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 781 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 2717 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 1191 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2005 | 480 | 0.010 |
Why?
|
Cell Line | 1 | 2005 | 2756 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 2397 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2005 | 712 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 1695 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2005 | 1896 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 3154 | 0.010 |
Why?
|
Time Factors | 1 | 2004 | 6323 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 5845 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 19221 | 0.000 |
Why?
|